NTRK2 and Alzheimer disease: However, increased expression of full-length TrkB, which contains a catalytic kinase domain that can be activated [36,37], is observed in glial cells in the hippocampus of AD patients [38], suggesting the existence of a hippocampal neuroprotective system in AD patients.